• Acquisition of Fovea Pharmaceuticals by Sanofi-aventis group accomplished in 2009 is the first steps towards the recent creation of the Ophthalmology division of Sanofi-aventis. This new Division will combine the expertise and resources needed from both Fovea and Sanofi-aventis to significantly grow the business and demonstrate the efficacy of products through regulatory clinical development. read more
Highlight
• February 10, 2009
Fovea Reports Positive Results with Prednisporin™ in Persistent Allergic Conjunctivitis read more
Agenda
ARVO’s 2011 Annual Meeting Fort Lauderdale FL, May 1-5 2011
117ème Congrès de la Société Française d'Ophtalmogie au 10 mai 2011, Palais des Congrès de Paris
Society of Toxicology’s 50th Anniversary Annual Meeting & ToxExpo™ ashington D.C., March 6–10, 2011
